177 related articles for article (PubMed ID: 24996439)
21. Ouabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agents.
Jun DW; Hwang M; Kim HJ; Hwang SK; Kim S; Lee CH
PLoS One; 2013; 8(10):e75905. PubMed ID: 24124520
[TBL] [Abstract][Full Text] [Related]
22. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
[TBL] [Abstract][Full Text] [Related]
23. The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells.
Zhao L; Li Y; He M; Song Z; Lin S; Yu Z; Bai X; Wang E; Wei M
Int J Oncol; 2014 Jul; 45(1):129-38. PubMed ID: 24789349
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
Wang Z; Li M; Lu S; Zhang Y; Wang H
Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
[TBL] [Abstract][Full Text] [Related]
25. New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein.
Fei P; Yin J; Wang W
Cell Cycle; 2005 Jan; 4(1):80-6. PubMed ID: 15611632
[TBL] [Abstract][Full Text] [Related]
26. Analysis of a FANCE Splice Isoform in Regard to DNA Repair.
Bouffard F; Plourde K; Bélanger S; Ouellette G; Labrie Y; Durocher F
J Mol Biol; 2015 Sep; 427(19):3056-73. PubMed ID: 26277624
[TBL] [Abstract][Full Text] [Related]
27. PARP inhibitor re‑sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis.
Wu J; Xiao S; Yuan M; Li Q; Xiao G; Wu W; Ouyang Y; Huang L; Yao C
Mol Med Rep; 2019 Jan; 19(1):75-84. PubMed ID: 30431088
[TBL] [Abstract][Full Text] [Related]
28. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway.
Rothfuss A; Grompe M
Mol Cell Biol; 2004 Jan; 24(1):123-34. PubMed ID: 14673148
[TBL] [Abstract][Full Text] [Related]
29. Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling.
Yu J; Chen WX; Xie WJ; Chen RW; Lin DQ; You WW; Ye WL; Zhang HQ; Lin DH; Xu JP
J Clin Lab Anal; 2021 Aug; 35(8):e23817. PubMed ID: 34114685
[TBL] [Abstract][Full Text] [Related]
30. Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R.
Xiao H; Xiao Q; Zhang K; Zuo X; Shrestha UK
Ann Hematol; 2010 Apr; 89(4):399-404. PubMed ID: 19756599
[TBL] [Abstract][Full Text] [Related]
31. BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer.
Nakashima S; Kobayashi S; Nagano H; Tomokuni A; Tomimaru Y; Asaoka T; Hama N; Wada H; Kawamoto K; Marubashi S; Eguchi H; Doki Y; Mori M
Cancer Sci; 2015 May; 106(5):584-91. PubMed ID: 25736055
[TBL] [Abstract][Full Text] [Related]
32. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light.
Dunn J; Potter M; Rees A; Rünger TM
Cancer Res; 2006 Dec; 66(23):11140-7. PubMed ID: 17145857
[TBL] [Abstract][Full Text] [Related]
33. DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications.
Shukla P; Solanki A; Ghosh K; Vundinti BR
Eur J Haematol; 2013 Nov; 91(5):381-93. PubMed ID: 23859405
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation.
Fan S; Twu NF; Wang JA; Yuan RQ; Andres J; Goldberg ID; Rosen EM
Int J Cancer; 1998 Aug; 77(4):600-9. PubMed ID: 9679765
[TBL] [Abstract][Full Text] [Related]
35. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
36. RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway.
Xie J; Kim H; Moreau LA; Puhalla S; Garber J; Al Abo M; Takeda S; D'Andrea AD
J Clin Invest; 2015 Apr; 125(4):1523-32. PubMed ID: 25751062
[TBL] [Abstract][Full Text] [Related]
37. Potential Doxorubicin-Mediated Dual-Targeting Chemotherapy in FANC/BRCA-Deficient Tumors via Modulation of Cellular Formaldehyde Concentration.
Nakamura J
Chem Res Toxicol; 2020 Oct; 33(10):2659-2667. PubMed ID: 32876438
[TBL] [Abstract][Full Text] [Related]
38. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
39. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.
Taniguchi T; Tischkowitz M; Ameziane N; Hodgson SV; Mathew CG; Joenje H; Mok SC; D'Andrea AD
Nat Med; 2003 May; 9(5):568-74. PubMed ID: 12692539
[TBL] [Abstract][Full Text] [Related]
40. Expression profile of Notch-related genes in multidrug resistant K562/A02 cells compared with parental K562 cells.
Yan S; Ma D; Ji M; Guo D; Dai J; Zhao P; Ji C
Int J Lab Hematol; 2010 Apr; 32(2):150-8. PubMed ID: 19302234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
